{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-056198","form_type":"8-K","ticker":"ALLO","cik":"0001737287","company_name":"Allogene Therapeutics, Inc.","filed_at":"2026-08-12T20:12:27+00:00","discovered_at":"2026-08-12T20:13:00.463854+00:00","generated_at":"2026-08-12T20:13:06.012380+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Allogene Q2 2026: Cema-Cel MRD clearance 58.3% vs 16.7%; FDA grants RMAT and Fast Track","bullets":["Cema-Cel ALPHA3 interim analysis: 58.3% (7/12) MRD-negative vs 16.7% (2/12) observation; 41.6% absolute difference.","FDA granted RMAT and Fast Track designations for cema-cel as 1L LBCL consolidation after interim futility review.","Site activations accelerated: >80 sites six months early; ~100 sites expected by year-end 2026; enrollment complete by YE2027.","Q2 2026 net loss $42.7M ($0.13/share); cash $423.6M, runway into 2029; 2026 GAAP opex ~$225M.","ALLO-329 RESOLUTION trial enrolling briskly; clinical data update expected Q4 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-056198","json":"https://secwatch.observer/filing/0001628280-26-056198.json","markdown":"https://secwatch.observer/filing/0001628280-26-056198.md","text":"https://secwatch.observer/filing/0001628280-26-056198.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737287/000162828026056198/0001628280-26-056198-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737287/000162828026056198/allo-20260812.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-12T20:13:06.012380+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}